References
- Bannister R, Oppenheimer DR. Degenerative diseases of the nervons system associated with autonomic failure. Brain 1972;95:457-74 https://doi.org/10.1093/brain/95.3.457
- Spokes EG, Bannister R, Oppenheimer DR. Multiple system atrophy with autonomic failure: Clinical, histological and neurochemical observations in four cases. J Neurol Sci 1979;43:59-82 https://doi.org/10.1016/0022-510X(79)90073-X
- Feamley JM, Lees A. Striatonigral degeneration. A clinicopathological study. Brain 1990;113:1823-43 https://doi.org/10.1093/brain/113.6.1823
- Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. The clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain 1994;117:835-45 https://doi.org/10.1093/brain/117.4.835
- Quinn N. Multiple system atrophy: the nature of the beast. J Neurol Neurosurg Psychiatry 1989;32:1358-63 https://doi.org/10.1136/jnnp.52.Suppl.78
- Litvan I, Goetz CG, Jankovic J, Wenning GK, Booth V, Bartko JJ, et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Acta Neurol 1997;54:937-44 https://doi.org/10.1001/archneur.1997.00550200007003
- Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quim NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133-47 https://doi.org/10.1002/mds.870120203
- Kaufman MJ, Madras BK Severe depletion of cocaine recognition sites associated with the dopamin transporter in Parkinson's disease striatum. Synapse 1991;9:43-9 https://doi.org/10.1002/syn.890090107
- Niznik HB, Fogel EF, Fassos FF, Seeman P. The dopamine transporter is absent in parkinsonism putamen and rednced in caudate nuclens. J Neurochem 1991;56:192-8 https://doi.org/10.1111/j.1471-4159.1991.tb02580.x
-
Br
${\ddot{u}}cke T, Djamshidian S, Bencsits G, Pirker W, Asenbaum S, Podreka I. SPECT and PET imaging of the dopaminergic system in Parkinson's disease. J Neurol 2000;247(suppl 4):2-7 https://doi.org/10.1007/PL00007769 -
Kim YJ, Ichise M, Ballinger JR, Vines D, Erami SS, Tatschida T, et al. Combination of dopamine transporter and
$D_2$ receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Mov Disord 2002; 17:303-12 https://doi.org/10.1002/mds.10042 -
Pirker W, Asenbaum S, Bencsits G, Prayer D, Gerschlager W, Deecke L, et al. [
$^{123}I$ ]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and cortocobasal degeneration. Mov Disord 2000;15:1158-67 https://doi.org/10.1002/1531-8257(200011)15:6<1158::AID-MDS1015>3.0.CO;2-0 -
Varrone A, Marek KL, Jennings D, Innis RB, Seibyl JP. [
$^{123}I$ ] beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Mov Disord 2001;16:1023-32 https://doi.org/10.1002/mds.1256 - Benarroche EE, Schmeichel AM, Low PA, Parisi JE. Involvement of medullary serotonergic groups in multiple system atrophy. Ann Neurol 2004;55:418-22 https://doi.org/10.1002/ana.20021
-
Patel T, Marek K, Innis RB, Seibyl JP. No difference in 5-HT transporter density in idiopathic Parkinson's disease subjects and healthy controls using
$^{123}I-{\Beta}-CIT$ SPECT. J Nucl Med 2000; 41(suppl):221 -
Kim SE, Choi JY, Choe YS, Choi Y, Lee WY. Serotonin transporters in the midbrain of Parkinson's disease patients : a study with
$^{123}I-{\Beta}-CIT$ SPECT. J Nucl Med 2003;44:870-6 -
Neumeyer JL, Wang SY, Milins RA, Baldwin RM, Zea-Ponce Y, Hoffer PB, et al.
$^{123}I-2{\Beta}-$ -carbomethoxy-$3{\Beta}$ -(4-iodo-phenyl)tropane (${\Beta}-CIT$ ). High affinity SPECT radiotracer of monoamine reuptake sites in brain. J Med Chem 1991;34:3144-6 https://doi.org/10.1021/jm00114a027 -
Boja JW, Mitchell WM, Patel A, Kopajtic TA, Carroll FI, Lewin AH, et al. High-affinity binding of [
$^{125}I$ ]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 1992;12:27-36 https://doi.org/10.1002/syn.890120104 -
Booij J, Andringa G, Rijks LJ, Vermeulen RJ, De Bruin K, Boer GJ, et al. [
$^{125}I$ ] FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP lesioned monkeys. Synapse 1997;27:183-90 https://doi.org/10.1002/(SICI)1098-2396(199711)27:3<183::AID-SYN4>3.0.CO;2-9 -
Booij J, Tissingh G, Boer GJ, Speehuan JD, Stoof JC, Janssen AG, et al. [
$^{125}I$ ] FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;62:133-40 https://doi.org/10.1136/jnnp.62.2.133 - Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, et al. Imaging of dopamine transporters with iodine-123-FP CIT SPECT in healthy controls and patients with Parkinson's disease. J Nucl Med 1998;39:1879-84
-
Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, et al. Iodine-123 N-omega-fluoropropyl-2
${\Beta}$ - carbomethoxy-3${\Beta}$ -(4-iodophenyl)tropane SPEeT in healthy controls and early-stage, drug-naive Parkinson's disease. J Nucl Med 1998;39:1143-8 - Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4 https://doi.org/10.1136/jnnp.55.3.181
- Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-8 https://doi.org/10.1016/S0022-510X(98)00304-9
- Okada T, Fujita M, Shimada S, Sato K, Schloss P, Watanabe Y, et al. Assessment of affinities of beta-CIT, beta-CIT-FE, and beta-CIT-FP for monoamine transporter permanently expressed in cell lines. Nul Med & Biol 1998;35:53-8
- Neumeyer JL, Tamagnan G, Wang S, Gao Y, Miliius RA, Kula NS, et al. N-substituted analogs of 2 beta-carbomethoxy-3 beta-(4'-iodophenyl)tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain. J Med Chem 1996;39:543-8 https://doi.org/10.1021/jm9505324
-
G
${\ddot{u}}$ nther I, Hall H, Halldin C, Swahn CG, Farde L, Sedvall G.$[^{125}I$ ]${\Beta}$ -CIT-FD and G.$[^{125}I$ ]${\Beta}$ -CIT-FP are superior to G.$[^{125}I$ ]${\Beta}$ -CIT for dopamine transporter visualization : Autoradiographic evaluation in the human brain. Nul Med & Bioi 1997;24:629-34 https://doi.org/10.1016/S0969-8051(97)00081-4 -
Berding G, Br
${\ddot{u}}$ cke T, Odin P, Brooks DJ, Kolbe H, Gielow P, et al.$[^{125}I$ ] beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy. Nuklearmedizin 2003;42:31-8 -
Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, et al. Reduced brain serotonin transporter availability in major depression as measured by
$[^{125}I$ ]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomogrphy. Biol Psychiatry 1998;44:1090-8 https://doi.org/10.1016/S0006-3223(98)00272-8 -
Willeit M, Praschak-Rieder N, Neumeister A, Pirker W, Asenbaum S, Vitouch O, et al.
$[^{125}I$ ]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiat 2000;47:482-9 https://doi.org/10.1016/S0006-3223(99)00293-0 - Tohgi H, Abe T, Takahashi S, Tahahashi J, Hamato H. Concentrations of serotonin and its related substances in the cerebrospinal fluid of Parkinsonian patients and their relations to the severity of symptoms. Neurosci Lett, 1993; 150: 71-4 https://doi.org/10.1016/0304-3940(93)90111-W
-
Chinaglia G, Landwehrmeyer B, Probst A, Palacios JM. Serotonergic terminal transporters are differentially affected in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study with [
$^{3}H$ ]citalopram. Neuroscience 1993;54:691-9 https://doi.org/10.1016/0306-4522(93)90240-G - Halliday GM, Blumbergs PC, Cotton RGH, Blessing WW, Geffer LB. Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease. Brain Res 1990;510:104-7 https://doi.org/10.1016/0006-8993(90)90733-R
- Miyawaki E, Meah Y, Koller We. Serotonin, dopamine, and motor effects in Parkinson's disease. Clin Neuropharmacol 1997;20:300-310 https://doi.org/10.1097/00002826-199708000-00002
-
Haapaniemi TH, Ahonen A, Torniainen P, Sotaniemi KA, Myllyla VV. [
$^{123}I$ ]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients. Mov Disord 2001;167:124-30